Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

The Lancet Oncology
M ToiH Bando

Abstract

Since the discovery that cancer development requires the growth of new blood vessels, many investigations have revealed the key molecules in the regulation of new vessel formation. One of the most important of these molecules is vascular endothelial growth factor (VEGF)--an endothelial-cell-specific mitogen and survival factor. VEGF also causes increased vascular permeability and recruits progenitor endothelial cells from the bone marrow. Clinical observations have confirmed that VEGF status is closely associated with the extent of neovascularisation and prognosis in many solid tumours. VEGF status is predictive of resistance to various treatments, including radiotherapy, chemotherapy, and endocrine therapy. Preliminary results also indicate that anti-VEGF treatment suppresses cancer progression without serious toxic effects. Various approaches for the control of cancers involving inhibition of the activity of VEGF are currently being investigated. This review considers the clinical implications of VEGF, particularly its prognostic, predictive, and therapeutic value.

References

Jan 15, 1997·Journal of the National Cancer Institute·G GaspariniT Tominaga
Mar 17, 2000·International Journal of Cancer. Journal International Du Cancer·B LinderholmR Henriksson
Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·D M AebersoldV Djonov
Aug 26, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G U Dachs, G M Tozer
Dec 5, 2000·Current Opinion in Biotechnology·N Ferrara
Jan 9, 2001·The Journal of Investigative Dermatology. Symposium Proceedings·J RakR S Kerbel
Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D MechtcheriakovaE Hofer
Feb 22, 2001·Journal of the National Cancer Institute·R BosE van der Wall
Mar 30, 2001·The Journal of Biological Chemistry·Z Gluzman-PoltorakG Neufeld
Aug 2, 2001·Journal of the National Cancer Institute·A CostaM G Daidone
Oct 1, 2003·Angiogenesis·A P AdamisR A D'Amato

❮ Previous
Next ❯

Citations

Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Shigehira SajiMasakazu Toi
Jul 1, 2008·Der Urologe. Ausg. A·A HeidenreichD Pfister
Mar 21, 2007·Cancer Chemotherapy and Pharmacology·R Longo, G Gasparini
Apr 19, 2007·Cancer Metastasis Reviews·Peter Vaupel, Arnulf Mayer
Oct 12, 2011·Investigational New Drugs·George R Blumenschein
Apr 16, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Enric Carcereny CostaPere Gascón Vilaplana
Nov 26, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohammad Atiqur Rahman, Masakazu Toi
Feb 26, 2004·Experimental Cell Research·Geir Olav HjortlandOlav Engebraaten
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F J HoarP S Stonelake
Nov 24, 2011·Rheumatology·Nia Emami-Shahri, Thorsten Hagemann
Feb 19, 2010·The Cancer Journal·Sally Greenberg, Hope S Rugo
Jul 27, 2011·Therapeutic Advances in Medical Oncology·L Y DirixP B Vermeulen
Nov 26, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Shin-ichi Nihira
Oct 4, 2005·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Sumithra J MandrekarDaniel J Sargent
Nov 16, 2005·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Katsumasa KuroiShinya Saito
May 9, 2007·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroko Bando
Jul 7, 2007·Neurosurgical Focus·Martin A BaggenstosRussell R Lonser
Feb 3, 2012·The Libyan Journal of Medicine·Canan AlkimMehmet Sokmen
May 4, 2012·World Journal of Gastroenterology : WJG·Junichi TakinoMasayoshi Takeuchi
Feb 8, 2003·Lancet·Tihomir Stefanec
Mar 1, 2014·Drugs·Bilal PiperdiRoman Perez-Soler
Jan 9, 2010·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Soo Jung LeeWansik Yu
Jun 26, 2012·Pathologie-biologie·D Molnar-StanciuA Thiery-Vuillemin
Mar 13, 2012·Critical Reviews in Oncology/hematology·Peter M Ellis, Khalid Al-Saleh
Jul 1, 2011·Critical Reviews in Oncology/hematology·Antoinette Wozniak
Feb 4, 2016·International Journal of Inflammation·Canan AlkimIlker Sen
Dec 16, 2005·Clinical Lung Cancer·David Raben, Anderson Ryan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.